作为神经炎症疾病治疗点的XI因子
Berk Taskin1, Tia C L Kohs1, Joseph J Shatzel1,2
1Department of Biomedical Engineering.
凝血因子XI (FXI) 通过增加神经炎症和血脑屏障透性,在多发性硬化症 (MS) 发病过程中发挥关键作用. 准FXI为治疗多发性硬化和其他神经炎症疾病提供了一个有前途的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 多发性硬化症 (MS) 是一种常见的自身免疫性疾病,导致神经炎症和血脑屏障 (BBB) 功能障碍.
- 凝血因子如血和纤维素与加剧MS相关的炎症和BBB透性有关.
- 将MS与受损的BBB功能联系在一起的精确机制尚未完全理解.
结论:
- FXII和FXI是BBB功能和神经炎症中免疫反应的关键调节者.
- 通过减轻神经炎症和BBB分解,FXI抑制表明MS的治疗潜力.
- FXI 抑制剂可能为神经炎症性疾病提供一种新的治疗途径,超出了它们在血栓形成中的既定用途.
更多相关视频
12:24Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
Published on: June 3, 2014
11:18Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
Published on: April 2, 2013
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Clot Retraction and Fibrinolysis
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
